NICOLE STEVENSON: Open Payments
NPI 1063727204 · PETERSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 93 payments from 19 companies in 2025. Trend: 2023 $1,354 · 2024 $1,346 · 2025 $1,609
Food & beverage: $1,609
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $322 |
| ABBVIE INC. | 25 | $275 |
| Axsome Therapeutics, Inc. | 15 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $151 |
| Otsuka America Pharmaceutical, Inc. | 8 | $138 |
| Novo Nordisk Inc | 6 | $121 |
| PFIZER INC. | 5 | $77 |
| Alkermes, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $52 |
| Globus Medical, Inc. | 1 | $44 |
Products named: Auvelity, CAPLYTA, REXULTI, VRAYLAR, BREZTRI, AIRSUPRA, Ozempic, FARXIGA.
Industry payments across IN — which companies pay providers there.
